INHIBIKASE THERAPEUTICS, INC. (IKT) Operating income 2020–2025
INHIBIKASE THERAPEUTICS, INC. (IKT) annual operating income history from SEC filings — each fiscal year as reported.
-$52.0MFY2025 · since FY2020: -$2.8M → -$52.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$52.0M | -81.8% |
| FY2024 | -$28.6M | -42.3% |
| FY2023 | -$20.1M | -10.8% |
| FY2022 | -$18.1M | -22.8% |
| FY2021 | -$14.8M | -423.9% |
| FY2020 | -$2.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice